IL127542A0 - Administration regimen of H+ K+ -ATPase inhibitors - Google Patents

Administration regimen of H+ K+ -ATPase inhibitors

Info

Publication number
IL127542A0
IL127542A0 IL12754297A IL12754297A IL127542A0 IL 127542 A0 IL127542 A0 IL 127542A0 IL 12754297 A IL12754297 A IL 12754297A IL 12754297 A IL12754297 A IL 12754297A IL 127542 A0 IL127542 A0 IL 127542A0
Authority
IL
Israel
Prior art keywords
administration regimen
atpase inhibitors
atpase
extended
profile
Prior art date
Application number
IL12754297A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL127542A0 publication Critical patent/IL127542A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL12754297A 1996-06-20 1997-06-18 Administration regimen of H+ K+ -ATPase inhibitors IL127542A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602442A SE9602442D0 (sv) 1996-06-20 1996-06-20 Administration of pharmaceuticals
PCT/SE1997/001098 WO1997048380A1 (en) 1996-06-20 1997-06-18 ADMINISTRATION REGIMEN OF H+, K+-ATPase INHIBITORS

Publications (1)

Publication Number Publication Date
IL127542A0 true IL127542A0 (en) 1999-10-28

Family

ID=20403092

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12754297A IL127542A0 (en) 1996-06-20 1997-06-18 Administration regimen of H+ K+ -ATPase inhibitors
IL127542A IL127542A (en) 1996-06-20 1998-12-13 H+, K+-ATPase INHIBITORS FOR USE IN IMPROVED INHIBITION OF GASTRIC ACID SECRETION

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL127542A IL127542A (en) 1996-06-20 1998-12-13 H+, K+-ATPase INHIBITORS FOR USE IN IMPROVED INHIBITION OF GASTRIC ACID SECRETION

Country Status (28)

Country Link
US (4) US20010008900A1 (xx)
EP (1) EP0921787B1 (xx)
JP (1) JP2000512993A (xx)
CN (1) CN1178648C (xx)
AT (1) ATE252885T1 (xx)
AU (1) AU726859B2 (xx)
BR (1) BR9709838A (xx)
CA (1) CA2257405A1 (xx)
CZ (1) CZ298213B6 (xx)
DE (1) DE69725860T2 (xx)
DK (1) DK0921787T3 (xx)
EE (1) EE04606B1 (xx)
ES (1) ES2208921T3 (xx)
HK (1) HK1018590A1 (xx)
HU (1) HUP9901794A3 (xx)
IL (2) IL127542A0 (xx)
IS (1) IS2216B (xx)
NO (1) NO323295B1 (xx)
NZ (1) NZ332990A (xx)
PL (1) PL189716B1 (xx)
PT (1) PT921787E (xx)
RS (1) RS49590B (xx)
RU (1) RU2203662C2 (xx)
SE (1) SE9602442D0 (xx)
SK (1) SK284204B6 (xx)
TR (1) TR199802647T2 (xx)
UA (1) UA64715C2 (xx)
WO (1) WO1997048380A1 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
AU3967399A (en) * 1998-04-30 1999-11-16 Sepracor, Inc. S-rabeprazole compositions and methods
EP1073332A4 (en) * 1998-04-30 2005-06-15 Sepracor Inc R-RABEPRAZOL COMPOSITIONS AND METHODS
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
ID28273A (id) 1998-08-10 2001-05-10 Partnership Of Michael E Garst Prodrug inhibitor pompa proton
SI1105105T1 (sl) 1998-08-12 2006-08-31 Altana Pharma Ag Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
WO1994024867A1 (en) * 1993-04-27 1994-11-10 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
UA41946C2 (uk) * 1994-07-08 2001-10-15 Астра Актієболаг Оральна фармацевтична складова одинична дозована форма у вигляді таблетки, спосіб її одержання, упаковка у вигляді блістера та спосіб інгібування секреції шлункової кислоти і/або лікування шлунково-кишкових запальних захворювань
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors

Also Published As

Publication number Publication date
PT921787E (pt) 2004-03-31
UA64715C2 (en) 2004-03-15
AU726859B2 (en) 2000-11-23
EP0921787B1 (en) 2003-10-29
CN1178648C (zh) 2004-12-08
HUP9901794A3 (en) 2002-11-28
DE69725860T2 (de) 2004-09-09
SE9602442D0 (sv) 1996-06-20
EP0921787A1 (en) 1999-06-16
JP2000512993A (ja) 2000-10-03
US20070276007A1 (en) 2007-11-29
CZ298213B6 (cs) 2007-07-25
ATE252885T1 (de) 2003-11-15
CZ420398A3 (cs) 2000-02-16
CA2257405A1 (en) 1997-12-24
EE9800435A (et) 1999-06-15
RS49590B (sr) 2007-06-04
HK1018590A1 (en) 1999-12-30
DE69725860D1 (de) 2003-12-04
TR199802647T2 (xx) 1999-03-22
SK284204B6 (sk) 2004-10-05
RU2203662C2 (ru) 2003-05-10
US20010008900A1 (en) 2001-07-19
IL127542A (en) 2006-08-01
US20090036494A1 (en) 2009-02-05
NO985964D0 (no) 1998-12-18
DK0921787T3 (da) 2004-02-23
CN1222074A (zh) 1999-07-07
NZ332990A (en) 2000-07-28
WO1997048380A1 (en) 1997-12-24
EE04606B1 (et) 2006-04-17
AU3469097A (en) 1998-01-07
SK165598A3 (en) 1999-08-06
NO323295B1 (no) 2007-03-05
PL330910A1 (en) 1999-06-07
HUP9901794A2 (hu) 2000-04-28
IS2216B (is) 2007-03-15
ES2208921T3 (es) 2004-06-16
NO985964L (no) 1999-02-22
PL189716B1 (pl) 2005-09-30
US20050113418A1 (en) 2005-05-26
BR9709838A (pt) 1999-08-10
IS4923A (is) 1998-12-15
YU56698A (sh) 2004-12-31

Similar Documents

Publication Publication Date Title
IL127542A0 (en) Administration regimen of H+ K+ -ATPase inhibitors
BG104619A (en) Oral pharmaceutical pulsed release dosage form
AP9701041A0 (en) Pyridylpyrrole compounds.
BG102259A (en) Compostions with controlled paroxetine release
AU7239996A (en) Inhibition of tumor necrosis factor alpha
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
AU1306795A (en) Anticonvulsant pseudofructopyranose sulfamates
LV11728A (lv) Farmaceitiska kompozicija
GEP20063719B (en) Prevention of Migraine Recurrence
AU1767297A (en) Benzo(C)quinolizine derivatives, their preparation and use as 5alpha-reductases inhibitors
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
BG101884A (en) Salts of the clavulanic acid
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
AU6970394A (en) Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
IL112110A0 (en) Octahydro-1h-isoindoles and pharmaceutical compositions containing them
GB9323404D0 (en) Pharmaceuticals
PL318539A1 (en) Inhibition of biosynthesis
NZ503559A (en) Compositions and methods for the control of smoking containing a xanthine oxidase inhibitor
MX9804798A (es) Nuevos compuestos con efecto analgesico.
MX9804797A (es) Nuevos compuestos con efecto analgesico.
MX9709438A (es) Ester-amidas de acido 3-hidroxi-piridina-2-carboxilico, su preparacion y su utilizacion como medicamentos.

Legal Events

Date Code Title Description
ERR Corrigendum

Free format text: IN JOURNAL 4/2006 P. 1507 PATENT APPLICATION NO. 127542 CORRECT DATE OF APPLICATION TO- 18.06.1997

FF Patent granted
KB Patent renewed
KB Patent renewed